Biotech Stock Roundup: REGN, MRNA Offer COVID-19 Updates, TBPH Down on Study Update

Posted byZacks Equity Research Leave a comment on Biotech Stock Roundup: REGN, MRNA Offer COVID-19 Updates, TBPH Down on Study Update

Regulatory and pipeline updates from Regeneron (REGN) and Moderna (MRNA), among others have been in focus in the biotech industry over the past week.

Leave a comment

Your email address will not be published. Required fields are marked *